Despite presenting similar phenotypes or sharing mechanisms implicated in neurodegenerative processes or MN degeneration,18 or clinical overlap, our data demonstrate that the molecular signature is not uniform in each case, indicating specificity of CXCL12 pathway alteration in ALS context. This evidence concerns the gene CXCL12 and amyotrophic lateral sclerosis.